A detailed history of Sippican Capital Advisors transactions in Organon & Co. stock. As of the latest transaction made, Sippican Capital Advisors holds 15,230 shares of OGN stock, worth $232,714. This represents 0.22% of its overall portfolio holdings.

Number of Shares
15,230
Previous 14,603 4.29%
Holding current value
$232,714
Previous $302,000 3.64%
% of portfolio
0.22%
Previous 0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$18.65 - $23.03 $11,693 - $14,439
627 Added 4.29%
15,230 $291,000
Q2 2024

Aug 06, 2024

BUY
$17.45 - $21.96 $12,581 - $15,833
721 Added 5.19%
14,603 $302,000
Q1 2024

May 02, 2024

BUY
$13.78 - $18.8 $191,293 - $260,981
13,882 New
13,882 $260,000
Q3 2023

Oct 24, 2023

BUY
$16.59 - $23.77 $270,748 - $387,926
16,320 Added 19.68%
99,232 $1.72 Million
Q2 2023

Aug 15, 2023

BUY
$19.27 - $24.63 $331,386 - $423,562
17,197 Added 26.17%
82,912 $1.73 Million
Q1 2023

Jul 14, 2023

BUY
$21.42 - $32.08 $270,427 - $405,010
12,625 Added 23.78%
65,715 $1.55 Million
Q4 2022

Jan 26, 2023

BUY
$23.31 - $28.61 $57,459 - $70,523
2,465 Added 4.87%
53,090 $0
Q3 2022

Oct 17, 2022

BUY
$23.4 - $34.25 $269,263 - $394,114
11,507 Added 29.42%
50,625 $1.19 Million
Q2 2022

Jul 19, 2022

BUY
$31.66 - $38.9 $7,376 - $9,063
233 Added 0.6%
39,118 $1.32 Million
Q1 2022

Apr 20, 2022

BUY
$30.45 - $39.36 $559,945 - $723,791
18,389 Added 89.72%
38,885 $1.36 Million
Q4 2021

Jan 19, 2022

BUY
$28.67 - $37.13 $386,299 - $500,289
13,474 Added 191.88%
20,496 $624,000
Q3 2021

Oct 20, 2021

BUY
$28.63 - $35.64 $201,039 - $250,264
7,022 New
7,022 $230,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Sippican Capital Advisors Portfolio

Follow Sippican Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Sippican Capital Advisors with notifications on news.